VANCOUVER, BC / ACCESSWIRE / March 14, 2019 / EViTRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the “Company”) is pleased to announce the appointment of Dr. Cataldo-Hernández to its Scientific Advisory Board.
Dr. Macarena A. Cataldo-Hernández has a PhD in chemical engineering from the Polytechnic University of Turin in Italy. Dr. Cataldo-Hernandez conducted ground-breaking Postdoctoral research at the University of British Columbia, pioneering the development of cutting-edge technology to clean and purify toxins and pollutants from contaminated drinking-water. With an extensive record of peer-reviewed publications and pendent patents, Dr. Cataldo-Hernandez is now using her extensive knowledge towards “green” industrial processes and applications. She works with companies ranging from oil and gas to medical cannabis, helping to scale their extraction, and technology from the lab to the field, in an eco-friendly and sustainable manner. In addition, Dr. Cataldo-Hernandez is also an adjunct professor at the Pontifical Catholic University of Valparaiso, where she teaches and supervises the next generation of “green” process engineers. She is also on the Board of Directors for Vancouver Coop Radio and is co-host on the Cannabis Science Podcast.
Management believes that the Company is fortunate to have someone with Dr. Cataldo-Hernandez’s knowledge and experience, as a scientific advisor to draw upon for chemical extraction and purification processes at a commercial scale to deliver improved health products, services and systems.
Management continues its commitment to elevate the human condition through advanced medical technology solutions for effective health, wellness research, and products.
EVITRADE Health Systems Corp.
(formerly Auxellence Health Corporation)
Email firstname.lastname@example.org or email@example.com
CSE Micro-site: http://thecse.com/en/listings/technology/evitrade-health-systems-corp
US OTC Markets (OTCQB): http://www.otcmarkets.com/stock/EVAHF/news
About EVITRADE Health (CSE: EVA, OTCQB: EVAHF)
EVITRADE Health Systems Corp. (formerly, Auxellence Health Corporation), is a technology company specializing in the Health and Life Sciences sector looking to deliver effective personalized health solutions with a higher degree of predictability and consistency.
The Company is focused on the following areas to help improve health: personalized medical care, molecular biology, nutraceutical solutions and genetic tailoring.
Through its subsidiaries’ focus on technologies involved in extracting and purifying CBD extracts for its personalized healthcare system, the Company may be the first to offer a complete quality assured vertically integrated “CBD Health System” for monitoring and recording the effects of CBD on your cardiovascular system.
This news release contains forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators and on the OTC Markets website which is posted on www.sedar.com, http://thecse.com/en/listings/technology/evitrade-health-systems-corp, and http://www.otcmarkets.com/stock/EVAHF/filings.This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), or any other regulatory authority accepts responsibility for the adequacy or accuracy of this release. The Company does not undertake to update this news release unless required by applicable law.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
SOURCE: EViTRADE Health Systems Corp.
View source version on accesswire.com: